TD Cowen analyst Bryan Bergin lowered the firm’s price target on Endava to $42 from $46 and keeps a Buy rating on the shares. The firm said 3Q was a mixed bag andthe company revised its 4Q organic view marking the low-end of its prior guide. Still, a message of stability and a more conservative guide posture were well-received.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA: